FC-076 • The mechanical effect of extracorporeal irradiation on bone
S. Gupta, D. Cafferky, F. Cowie, P. Riches, I. Anthony, A. Mahendra

FC-077 • Periprosthetic fractures after massive knee and hip prosthesis: a retrospective analysis of 21 cases
N. Barut, P. Anract, A. Babinet, D. Biau

FC-078 • Use of osteoarticular bone allografts in limb salvage reconstruction of the proximal tibia
L.C. Gomez, C. Soto, M. Maldonado, R. Sanchez

FC-079 • Joint sparing surgery using recycled tumor-bearing autograft for osteosarcoma
M. Miyagi, H. Katagiri, S. Hosaka, J. Wasa, H. Murata, M. Takahashi

FC-080 • Aseptic loosening of knee megaprosthesis: 22 years data analysys (the East-European Sarcoma Group)
A. Sokolovsky, M. Aliev, V. Sokolovsky, P. Sergeev, A. Sukhov

FC-081 • Long-term results of knee replacement with MUTARS^® modular endoprostheses in treatment of primary tumors
M. Bus, M. van de Sande, S. Dijkstra

FC-082 • Uni- or bipolar proximal femoral endoprostheses following tumour reconstruction: are acetabular resurfacings necessary?
J. Stevenson, V. Kumar, G. Cribb, P. Cool

FC-083 • Endoprosthetic failure after resection of primary or secondary bone tumors in the proximal humerus and reconstruction with the MUTARS™ system – A systematic analysis
D. Andreou, J.N. Broking, G. Gosheger, J. Wilhelmy, M.-P. Henrichs, M. Nottrott, J. Hardes, A. Streitburger

FC-084 • Intercalary allograft reconstruction after resection of primary bone tumors
L. Pazourek, M. Mahdal, T. Toma, P. Janjek, J. Cerny, S. Ondrusek

FC-085 • Results of massive osteochondral allograft reconstruction for tumors at the knee area
T. Tomas, P. Janjek, J. Cerny, S. Ondrjek, L. Pazourek, M. Mahdal

NS-06 • Retrospective analysis of the management of the high-risk bleeding sarcoma patient with bleeding-preventing intravascular device
R. Leoni, R. Martinelli, A. Cipriano, F. Salassa, M. De Bergolis, G. Bax, M. Garofalo, N. Albanese, P. Benotto

NS-07 • Physical exercise in patients with osteosarcoma or Ewing sarcoma in the lower extremity: a literature study
D.C.G. Boonman, I. van Dooren, K.A. de Groot, S.C. Scheurwater, J.C. Boiten, H.M. Vermeulen, W.P. Bekkering

NS-08 • Quality of life after malignant bone cancer surgery; a long term follow-up study
W.P. Bekkering, J.C. Egmond-van Dam, J.A.M. Bramer, A. Beishuizen, M. Fiocco, P.D.S. Dijkstra

NS-09 • Intravenous chemotherapy at home
P. Arvaniti, D. Venetis, T. Theodoropoulos, T. Pylios

NS-10 • Computer use, staff hygiene and infections in Orthopedic Clinic:/em>
D. Petroudi

FC-097 • Soft tissue sarcoma abutting the bone, does it carry a worse prognosis, and what surgery is the most appropriate?
A. Shehadeh

FC-098 • Marginal resection for lipomas and atypical lipomatous tumors of the extremities: retrospective comparison with histology and MDM2 gene amplification
C. Errani, S. Cocchi, N. Ali, M. Chehrassan, A. Righi, D. Donati

FC-099 • What is the significance of a fungating soft tissue sarcoma?
R. Grimer, M. Parry, H. Wafa, S. Sugath

FC-100 • The “two-week wait" referral system: how predictive of malignancy are the worrying features for soft tissue sarcomas?
M. Smolle, A. Leithner, R. Grimer

FC-101 • Aggressive primary synovial chondromatosis of the hip
W.J. Anderson, M. Vlychou, Y. Inagaki, D. Whitwell, C.L.M.H. Gibbons, N.A. Athanasou

FC-102 • Re-excision of residual sarcomas ("second-look surgery"): analysis of our results
A. Peiro, I. Gracia, L. Trullols, A. Garcia, M. Angelica, O. Buezo

FC-103 • Extraskeletal chondrosarcomas: how to identify bad prognostic factors for local recurrence and survival?
U. Albertini, M. Boffano, S. Marone, E. Boux, G. Grignani, A. Linari, A. Comandone, R. Piana

FC-104 • IMRT delivery of preoperative high dose radiotherapy with Simultaneous Integrated Boost (SIB) in retroperitoneal sarcomas: a feasibility study
S. El-Sayed, K. Carty

FC-105 • Myxofibrosarcoma: a particularly difficult-to-treat soft tissue sarcoma – Considerations from a series of 85 patients
G. Scoccianti, G. Beltrami, A. Franchi, F. Frenos, M. Faccio, R. Capanna

FC-106 • Sarcoma of the foot: changes in amputation rate over one decade
O. Tendero, I. Felipe-Abrio, P. Sancho, J. Martin-Broto, I. Monge, D. Salinas, R. Ramos, I. Alastuey, P. Luna, J. Estrada, L. Muntaner, A. Ballesteros

FC-086 • Proximal tibia reconstruction after primary bone tumor resections: endoprosthetic replacement versus osteoarticular allograft
J. Albergo, L. Muscolo, R. Grimer, L. Gaston Czar, L. Aponte-Tinao, L. Jeys, G. Farfalli, S. Carter, M. Ayerza, R. Tillman, A. Abudu

FC-087 • Silver ions levels in body fluids and clinical results in silver-coated megaprostheses: a 1 to 4 years follow-up
G. Scoccianti, G. Beltrami, M. Ippolito, F. Frenos, A. D'Arienzo, R. Capanna

FC-088 • The vascularized fibular graft for limb salvage after bone tumor surgery: a multicentre study
Oxford Sarcoma Service (OSS), Dutch Orthopaedic Tumour Society (DOTS)

FC-089 • Is silver worthwhile on all endoprostheses?
R. Grimer, M. Parry, L. Jeys

FC-090 • Biological extramedullary fixation in limb salvage surgery with HA collars
I. Papakostas, G. Alexiadis, S. Sarafopoulos, C. Tzouros, S. Dara, T. Kormas

FC-091 • Allografts in children and adolescents after resection of malignant bone tumors
A. Vaquero-Picado, E. Ferrer Santacreu, J. De Las Heras Sotos

FC-092 • Use of tricortical autologous graft from iliac crest reconstruction of long bone defects after block resection in tumor indications
J. Lesensky, Z. Matejovsky

FC-093 • Massive intercalary allograft reconstruction after long bone tumor resection
M. Bergovec, M. Smerdelj, V. Radočaj, K. Barbaric, A. Bonevski

FC-094 • Are we aggressive in performing two-stage reimplantation for periprosthetic infection after tumor resection around knee?
S. Bindiganavile, M. Depaolis, C. Romagnoli, M. Romantini, D.M. Donati

FC-095 • Infected tumor prostheses: a review of 125 cases from two institutions
E. Pala, P. Ruggieri, A.F. Mavrogenis, A. Angelini, G. Trovarelli, B. Haddad, C. Vottis, T. Calabrò, V. Igoumenou, P.J. Papagelopoulos

FC-096 • Massive resection of diaphyseal primary bone sarcomas and reconstruction using recycled pasteurized tumor segment
A. Rafalla

FC-107 • Extra-abdominal desmoid tumor: prognostic factors and clinical outcome in a surgical series
M.W. Joo, Y.-K. Kang, Y.-G. Chung, W.-J. Bahk

FC-108 • The impact of “extended surgical procedures” on the outcome of soft tissue sarcomas
C. Stihsen, C. Novak, J. Panotopoulos, R. Windhager, P. Funovics, Philipp

FC-109 • Prognostic factors and follow-up strategy for superficial soft-tissue sarcomas: analysis of 2626 surgically treated patients from the Scandinavian Sarcoma Group register
P. Tsagozis, H. Bauer, E. Styring, C. Trovik, O. Zaikova, O. Brosjo

FC-110 • Outcome following resection of synovial sarcoma – Analysis of prognostic factors with a minimal follow up of 5 years
U. Lenze, E. Hylla, F. Pohlig, F. Lenze, J. Schauwecker, R. Gradinger, H. Rechl, R. von Eisenhart-Rothe

FC-111 • Atypical lipomatous tumor and liposarcoma of the musculoskeletal system – Outcome analysis with a minimal follow up of 5 years
U. Lenze, J. Breitenbach, F. Pohlig, F. Lenze, C. Knebel, A. Toepfer, H. Rechl, R. von Eisenhart-Rothe

FC-112 • Single institution experience of isolated limb perfusion with melphalan in treatment of advanced extremity melanoma and soft tissue sarcomas
N. Petrachenko, T. Kharatishvili, Y. Buydenok, B. Narkevich, D. Martynkov, A. Fedenko, M. Aliev

FC-113 • Soft tissue sarcomas in patients over 65 years old. Clinical outcomes of different subgroups from a regional centre in the UK
Z. Khan, C.F. Yiu, W. Wignadasan, C.J. Richards, C.P. Esler, S. Carvell, R.U. Ashford

FC-114 • 5-Aminolevulinic acid photoablation of fibrotic soft-tissue tumors
J. Bickels, Y. Gortzak, A. Sternheim, Y. Kollender

FC-115 • Extraabdominal desmoid tumors – From watchful waiting to extensive surgery: results of different treatment modalities in Switzerland
A.H. Krieg, C. Wirth, C. Kettelhack, D. Baumhoer, F. Klenke, K. Siebenrock, U. Exner, B. Bode, B. Fuchs, F. Hefti

FC-116 • Adjuvant radiotherapy in leiomyosarcomas and liposarcomas – Experience of a center
A. Branquinho, D. Macedo, A. Mansinho, I. Fernandes, D. López, F. Pina, J. Portela, H. Vasques, M. Jorge, L. Costa

FC-117 • Chondrosarcoma in children and adolescents – Are they different?
A. Puri, A. Gulia, R. Vishnu

FC-118 • Vectorization of hypoxia activated prodrugs to chondrosarcoma proteoglycans: evaluation and characterization of antitumoral activity
A. Voissiere, V. Weber, M.-M. Auplat, F. Degoul, J.-M. Chezal, F. Redini, E. Miot-Noirault, C. Peyrode

FC-119 • Surgical treatment of primary central conventional chondrosarcoma of pelvic bone: an evaluation of outcome in four European centers of orthopaedic oncology
M. Bus, D. Campanacci, A. Leithner, M. van de Sande, G. Caff, J. Mettelsiefen, R. Capanna, P.-U. Tunn, S. Dijkstra

FC-120 • Local recurrence following curettage and cementation of low-grade chondrosarcomas
M. Hiz, B. Gorgun, S. Kocak, S. Dervisoglu

FC-121 • Extended curettage followed by ethanol application and bone graft for grade 1 chondrosarcoma of the appendicular skeleton
M.W. Joo, Y.-G. Chung, Y.-K. Kang

FC-122 • Chondrosarcoma of the pelvis: a critical review of 58 consecutive patients from a single center cohort
C. Stihsen, S. Puchner, J. Panotopoulos, R. Schuh, R. Windhager, P. Funovics

FC-123 • Chondrosarcoma surveillance – The Stanmore experience
M. Brown, P. Gikas, J. Jagiello, W. Aston, J. Skinner, T. Briggs, R. Pollock

FC-124 • Chondrosarcoma of the pelvis a review of sixty five cases between 1996 and 2013
A. Salduz, G.A. Norambuena Morales, P.S. Rose, F.H. Sim, Franklin H.

FC-125 • Argon beam and high speed bur as adjuvants in the treatment of low grade cartilage tumors
M. Galli Serra, M.J. Portillo Franco, W.M. Parizzia

FC-126 • Chondrosarcoma of hand and feet – Review of 37 cases from single institution
J. Lesensky, Z. Matejovsky, I. Kofranek

FC-127 • Follow-up of untreated chondroid lesions in the long bones
I. van der Geest, C. Deckers, B. Schreuder

FC-128 • Surgery of pelvic chondrosarcomas: a review of 285 cases from two institutions
A. Angelini, A.F. Mavrogenis, E. Pala, G. Trovarelli, T. Calabrò, C. Vottis, P. Megaloikonomos, P. Papagelopoulos, P. Ruggieri

FC-129 • Giant cell tumor of bone in children and adolescents: a report of 10 cases
P. Arbelaez, F. Linares, J. Manrique, M. Fernadez

FC-130 • Clinical presentation and outcome of giant cell tumor of the pelvis and sacrum
G. Hoogzaad, J. Chan, L. Gaston, K. Reddy, S. Carter, L. Jeys, R. Grimer, S. Abudu

FC-131 • Denosumab – A new bullet in the armamentarium for giant cell tumor
A. Puri, A. Gulia, V. Verma

FC-132 • Sacral giant cell tumors – To operate or not to operate!
A. Puri, A. Gulia, M. Bhandari

FC-133 • Efficacy of Denosumab with special reference to its role in joint preservation as an adjuvant in the management of giant cell tumor of bone
F. Traub, B. Dickson, R. Mohankumar, M. Blackstein, A. Griffin, P. Ferguson, J. Wunder

FC-134 • Adjuvant zoledronic acid in high-risk giant cell tumor of bone – Preliminary results of a randomized phase II study
L. van der Heijden, S. Dijkstra, M. van de Sande, P. Jutte, H. Gelderblom, N. Hamdy, P. Hogendoorn, J. Kroep

FC-135 • Giant cell tumor of the distal radius: is resection better?
R. Turcotte, H. Sawan, P. Ferguson, J. Wunder, M. Isler, S. Mottard, J. Werier, H. Abdelbary

FC-136 • Is it possible to predict recurrence of giant cell tumor of bone – Our experience and dilemmas?
N. Lujic, J. Sopta, R. Kovacevic, R. Davidovic, S. Rajkovic, Z. Bascarevic, D. Ristic

FC-137 • Comparison of clinical results with bone allograft or PMMA after intralesional curettage for giant cell tumors of bone
P.F. Horstmann, P. Holmberg Jorgensen, W. Hettwer, B. Hauge Hansen, M. Mørk Petersen

FC-138 • Denosumab in giant cell tumor of bone: innovation or chimera?
G. Beltrami, G.G. Baldi, G. Scoccianti, A. D'Arienzo, F.R. Campo, F. Frenos, D.A. Campanacci, A. Franchi, R. Capanna

FC-139 • Clinical and pathological results of Denosumab in the treatment of giant cell tumor of the bone
M.A. Deveci, S. Paydayi, G. Gonlusen, C. Ozkan, O.S. Bicer, M. Tekin, I. Tan

FC-140 • Emerging role of Denosumab in the management of giant cell tumor of bone
W. Ebeid, M. Abdulla, R. Abdelmoneim, E. Saad, D. Ezzeldin

FC-141 • Prevention of infectious complications in children with bone tumors after the arthroplasty
M. Rykov, A. Dzampaev, V. Polyakov

FC-142 • Limb salvage in skeletal immature patients: Japanese experience
T. Ozaki, T. Kunisada, K. Takeda, T. Fujiwara

FC-143 • Outcome of pelvic bone sarcomas in children under 16 years of age
M. Laitinen, M. Parry, J. Albergo, A. Abudu, S. Carter, R. Tillman, L. Jeys, R. Grimer

FC-144 • Long-term follow-up of functional outcome after malignant bone cancer surgery around the knee
J. van Egmond-van Dam, P. Bekkering, J. Bramer, A. Beishuizen, M. Fiocco, S. Dijkstra

FC-145 • First report of X-pand tumor prosthesis experience in Ukraine
O. Vyrva, R. Malik, V. Baev

FC-146 • Fibrous displasia of craniofacial area in children and adolescents
D. Rogozhin, D. Konovalov, M. Bolotin, A. Lopatin, I. Boulytcheva, V. Roshin, A. Talalaev, A. Kugushev

FC-147 • The spectrum of bone giant cell lesions in children and adolescents
D. Rogozhin, A. Kugushev, D. Konovalov, M. Bolotin, A. Lopatin, I. Boulytcheva, V. Roshin, A. Ektova, A. Kuzin, A. Talalaev

FC-148 • Early management of pathological fractures in the skeletally immature
L. Bayliss, A. Simpson, P. Monk, N. Athanasou, A. Wainwright, M. Gibbons, T. Theologis

FC-149 • Expandable prosthesis in reconstructing distal femoral defects following tumor resection: evaluation of a two-stage procedure
W. Ebeid, W. Abousenna

FC-150 • Bone sarcomas of the proximal femur in small children: the challenge of hip reconstruction in a growing patient
M. Manfrini, M. Colangeli, L. Campanacci, M. De Paolis, D. Donati

FC-151 • Non-invasive growing prostheses in children affected by malignant tumors of the knee: early results from a single institution
A. Daolio Primo, S. Bastoni, F.L. Giardina, A. Della Valle, M.S. Bartoli, C. Meazza, M. Massimino

FC-152 • Short term experience with the Xpand non-invasive expandable endoprosthesis
Y. Gortzak, J. Bickels, A. Sternheim, Y. Kollender, A. Nirkin, D. Levin, S. Dadia

FC-153 • Expandable prosthesis in children after bone tumour resection of the distal femur. The experience of the Rizzoli Institute
E.L. Staals, M. Colangeli, N. Ali, E. Sebastiani, D. Donati, M. Manfrini

FC-154 • Internal hemipelvectomy – Possibility of reconstruction in children and youth with primary malignant bone tumors
A. Szafranski, M. Rychłowska-Pruszynska, B. Pachuta, I. Malesza, T. Walenta

FC-155 • Expandable endoprosthesis in children and adolescents after malignant tumor resection – Own experience
A. Szafranski, M. Rychłowska-Pruszynska, B. Pachuta, I. Malesza, T. Walenta

FC-156 • Limb salvage surgery for primary malignant bone tumors in children younger than 5 years
M. Rychłowska-Pruszyńska, A. Szafrański, B. Pachuta, M. Karwacki, A. Raciborska

FC-157 • Evidence of a monoclonal origin of tenosynovial giant cell tumor
L.A. Holzer, A. Weinhaeusel, B. Liegl-Atzwanger, K. Trieb, O.A. Haas, A. Leithner

FC-158 • Post-surgery wound fluid stimulates ex vivo soft sarcoma re-growth
F. De Nigris, M. Gallo, M. Di Somma, G. Colella, F. Fazioli

FC-159 • Chemotherapy revived - intraarterial cisplatin-based chemotherapy in an osteosarcoma xenograft model
B. Robl, S. Botter, M. Arlt, B. Fuchs

FC-160 • Metilation of p14ARF and p16INK4a – A possible role in the pathogenesis of liposarcoma
J. Sopta, R. Davidovic, R. Kovacevic, D. Ristic, J. Bokun, A. Djordjevic, N. Lujic, G. Djuricic

FC-161 • EURAMOS-1: results from the randomised questions of the first European-American osteosarcoma study
J. Whelan, S. Bielack, S. Smeland, N. Marina, T. Butterfass-Bahloul, G. Jovic, M. Sydes, M. Bernstein

FC-162 • L-MTP-PE and zoledronic acid association in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer
F. Redini, K. Bitau, J. Taurelle, R. Guiho, J. Chesneau, J. Amiaud, N. Corradini, D. Heymann

FC-163 • Navigated joint sparing bone tumor resections
A. Sternheim, J. Wunder, A. Kashigar, M. Daly, J. Qiu, R. Weersink, H. Chan, D. Jaffray, J. Irish, P. Ferguson

FC-164 • Halofuginone inhibits primary tumor growth and lung metastasis development in osteosarcoma
A. Lamora, M. Mullard, J. Amiaud, R. Brion, D. Heymann, F. Redini, F. Verrecchia

FC-165 • Blocking TGF-beta signaling pathway inhibits the development of osteosarcoma lung metastases
A. Lamora, J. Talbot, J. Amiaud, G. Bougras, M.C. Le Deley, D. Heymann, F. Redini, F. Verrecchia

FC-166 • A prospective cohort study using computer assistance during resection of musculoskeletal tumors
P. Young, A. Mahendra

FC-167 • Mifamurtide (L-MTP-PE) in children with osteosarcoma: the Turkish experience
R. Kebudi, I. Ilhan, M. Kantar, F. Cakir, E. Guler, N. Olgun, T. Celkan

FC-168 • Identification of CD146 as a marker of tumor-propagating cells in human sarcomas leads to novel treatment opportunities
J. Wunder, J. Tang Yuning, Q. Wei, H. Whetstone, L. Ailles, G. Bader, B. Alman

FC-169 • PET response criteria (PERCIST) predict progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma
W.P. Fendler, M. Lehmann, A. Todica, K. Herrmann, T. Knösel, M.K. Angele, H.R. Dürr, J. Rauch, S. Abdel-Rahman, R.D. Issels, P. Bartenstein, C.C. Cyran, M. Hacker, L. Lindner

FC-170 • Validation of EQ-5D in patients treated for extremity sarcoma
A. Suokas, G. Stephens, L. Gosling, R. Grimer

FC-171 • Proton beam radiotherapy for unresectable bone and soft tissue sarcoma
H. Katagiri, S. Murayama, T. Nishiumura, M. Takahashi, H. Murata, J. Wasa, S. Hosaka, M. Miyagi

FC-172 • Clinical and radiological presentation of osteoid osteoma of the foot
M. Bergovec, M.M. Gilg, L. Repsa, M. Smerdelj, A. Leithner

FC-173 • Laboratory based measurement of physical functioning after treatment for sarcoma using a triaxial accelerometer – A feasibility study
S. Furtado, A. Godfrey, B. Galna, C. Tseminidis, N. Rutter, T. Ploetz, D. Jameson, L. Rochester, C. Gerrand

FC-174 • Evaluating physical activity in the community after sarcoma treatment using triaxial accelerometry. A new paradigm for outcome assessment?
S. Furtado, C. Gerrand, A. Godfrey, B. Galna, C. Tseminidis, N. Rutter, A. Hickey, D. Jameson, T. Ploetz, L. Rochester

FC-175 • Service redesign for tertiary sarcoma referral service
P. Young, D. Wallace, H. Wafa, M. Halai, H. Findlay, A. Mahendra

FC-176 • Transhumeral amputees treated with the OPRA implant system – Results and future possibilities with bionic limbs integrated to the bone
O. Berlin, G. Tsikandylakis, R. Branemark

FC-177 • Oncologic and functional result after treatment of patients with fibular osteosarcoma
P. Ruggieri, G. Trovarelli, E. Pala, G.I. Piraino, T. Calabrò, B. Haddad, A.F. Mavrogenis, A. Angelini

FC-178 • Outcome of primary leiomyosarcoma of bone – Current evidence and a report of 21 cases from two musculoskeletal tumor centers
M. Willegger, S. Bronimann, R. Schuh, R. Nakayama, H. Morioka, R. Windhager, J. Panotopoulos, P.T. Funovics

FC-179 • Can feed-back based gait training in tumor arthroplasty influence motion sequence?
B. Lehner, R. Bitsch, R. Rupp, C. Schuld

FC-180 • Can neoadjuvant radiotherapy facilitate a safer resection and limb sparing surgery in the treatment of osteosarcoma?
H. Ozger, F. Agaoglu, M. Sungur, B. Alpan, N. Valiyev

FC-181 • Stereotactic Body Radiotherapy (SBRT) for the treatment of renal cell carcinoma metastases with oligometastatic disease
S.E. Wozniak, S. Horasak, A. Aboulafia